Maternal and fetal safety of intravenous immunoglobulin in women with reproductive failure,American Journal of Reproductive Immunology

当前位置： X-MOL 学术 › Am. J. Reprod. Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Maternal and fetal safety of intravenous immunoglobulin in women with reproductive failure
American Journal of Reproductive Immunology ( IF 3.6 ) Pub Date : 2021-08-07 , DOI: 10.1111/aji.13492
Aera Han _{1,

2} , Sung Ki Lee _{1,

3} , Jun Cheol Park ₄ , Chan Woo Park ₅ , Jae Won Han ₃ , Ki Hwan Lee ₆

Affiliation

Intravenous immunoglobulin G (IVIG) is an emerging regimen for women with reproductive failures (RF) during- or pre-pregnancy who have aberrant cellular immune reactions. Studies investigating teratogenicity of IVIG have been limited. Herein, we evaluated the fetal teratogenicity of IVIG and IVIG-related obstetric complications.

中文翻译：